Home

Krystal Biotech, Inc. - Common Stock (KRYS)

147.61
-2.39 (-1.59%)
NASDAQ · Last Trade: Jul 25th, 7:59 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Analyst Expectations For Krystal Biotech's Futurebenzinga.com
Via Benzinga · July 25, 2025
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · July 17, 2025
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Yearsbenzinga.com
Via Benzinga · July 4, 2025
Peering Into Krystal Biotech's Recent Short Interestbenzinga.com
Via Benzinga · July 2, 2025
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potentialfool.com
Via The Motley Fool · June 28, 2025
What Does the Market Think About Krystal Biotech?benzinga.com
Via Benzinga · May 28, 2025
Earnings Scheduled For May 6, 2025benzinga.com
Via Benzinga · May 6, 2025
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · March 3, 2025
Is the Market Bullish or Bearish on Krystal Biotech?benzinga.com
Via Benzinga · March 3, 2025
Demystifying Krystal Biotech: Insights From 7 Analyst Reviewsbenzinga.com
Via Benzinga · June 24, 2025
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · June 20, 2025
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · May 26, 2025
The Analyst Verdict: Krystal Biotech In The Eyes Of 12 Expertsbenzinga.com
Via Benzinga · May 16, 2025
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next
Via MarketBeat · May 14, 2025
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · February 24, 2025
A Glimpse Into The Expert Outlook On Krystal Biotech Through 9 Analystsbenzinga.com
Via Benzinga · February 20, 2025
Earnings Scheduled For February 19, 2025benzinga.com
Via Benzinga · February 19, 2025
Looking Into Krystal Biotech's Recent Short Interestbenzinga.com
Via Benzinga · February 11, 2025
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · May 9, 2025
Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Diseasebenzinga.com
Abeona's Zevaskyn secures timely FDA nod, priced at $3.1 million, with 2025 sales now forecast at $31.6 million and peak U.S. revenue projected at $600 million.
Via Benzinga · April 30, 2025
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Yearsbenzinga.com
Via Benzinga · April 28, 2025
Demystifying Krystal Biotech: Insights From 7 Analyst Reviewsbenzinga.com
Via Benzinga · April 28, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · April 14, 2025
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · March 19, 2025
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesdaybenzinga.com
Via Benzinga · March 5, 2025